STAAR Surgical Company
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving STAAR Surgical Company now
Current reporting with the operating signal separated from the noise.
STAAR Surgical Company (STAA) Discusses Differentiation of EVO ICL Technology and Market Trends in Refractive Surgery Transcript
The story matters when it changes STAAR Surgical Company’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Alcon Inc. Investors and STAAR Surgical Company: Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon's Acquisition of STAAR
The development tests whether STAAR Surgical Company can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.STAAR Surgical Company (STAA) Q1 2025 Earnings Call Transcript
Investors are testing whether STAAR Surgical Company’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.STAAR Surgical Company
The story matters when it changes STAAR Surgical Company’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest STAA filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
STAAR Surgical Company, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →